Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹232.77
0.88 (0.38%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.56K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
35.4
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹155+50.2%
52W High₹301.65-22.8%
Current Price
₹232.77
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹186.22
Upper Circuit₹279.32
Reference Price
₹232.77
Investment Checklist
Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹257.75
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹254.24
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 57.48 (STRONG_BUY) with 93.6% confidence
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
94%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
226.83
EMA50
215.83
EMA200
211.39
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹235.87
₹241.98
₹258.24
₹264.50
₹301.65
Support (Below)
₹229.75
₹225.37
₹222.00
₹219.36
₹214.50
Volume Analysis
TrendINCREASING
Change+606.00%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹230.44
3% Risk₹225.79
5% Risk₹221.13
7% Risk (Custom)
₹216.48Technical Levels
1x ATR (Volatility)₹221.64
2x ATR (Swing)₹210.51
3x ATR (Trend)₹199.38
Immediate Support₹229.75
Moving Averages
EMA 9 (Short-term)₹232.36
EMA 20 (Medium-term)₹226.83
EMA 50 (Trend)₹215.83
EMA 200 (Long-term)₹211.39
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹58.6 Cr | ₹75.6 Cr | ₹74.5 Cr | ₹72.9 Cr |
| Net Profit | ₹6.6 Cr | ₹10.8 Cr | ₹12.6 Cr | ₹11 Cr |
| EPS | — | ₹1.60 | ₹1.88 | ₹1.67 |
| Operating Profit | ₹11.2 Cr | ₹17 Cr | ₹19.5 Cr | ₹17.2 Cr |
ROE
23.07%
ROCE
28.38%
Debt/Equity
0.04
Current Ratio
6.22
OPM
23.53%
NPM
15.01%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Jagsonpal Pharmaceuticals Limited | ₹232.77 | +0.38% | 35.4 | ₹1.56K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 04 May 2026 | Buy Back | BUYBACK |
| 12 Sept 2025 | Dividend - Rs 2.50 Per Share | DIVIDEND |
| 08 Jan 2025 | Face Value Split (Sub-Division) - From Rs 5/- Per Share To Rs 2/- Per Share | STOCK_SPLIT |
| 06 Sept 2024 | Dividend - Rs 5 Per Share | DIVIDEND |
| 21 Aug 2023 | Dividend - Rs 5 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for JAGSNPHARM
View All
positive
Business Standard - Markets 11d ago
Jagsonpal Pharma rallies 14% on acquisition update; time to book profit?
Jagsonpal Pharmaceuticals has entered into a definitive agreement to acquire an 85 per cent equity stake in Aequitas Healthcare
HCGHCG-REHEALTHCAREJAGSNPHARMFinancial ServicesHealthcare
NEWS
positive
Business Standard - Markets 11d ago
Jagsonpal Pharma soars after inking pact to acquire majority stake in Aequitas
Jagsonpal Pharmaceuticals surged 9.79% to Rs 253.90 after the company entered into a definitive Agreement to acquire an 85% equity stake in Aequitas Healthcare (Aequitas), marking its entry into hospital segment.
HCGHCG-REHEALTHCAREJAGSNPHARMFinancial ServicesHealthcare
positive
CNBC TV18 - Markets 11d ago
Jagsonpal Pharmaceuticals to acquire 85% stake in Aequitas Healthcare for ₹21 crore
Shares of Jagsonpal Pharmaceuticals Ltd ended at ₹230.80, down by ₹8.05, or 3.61%, on the BSE.
BSEHCGHCG-REHEALTHCAREJAGSNPHARMMOHEALTHFinancial ServicesHealthcare